Stem cells as a potential future treatment of pediatric intestinal disorders

Journal of Pediatric Surgery

Volumn 43, Issue 11, 2008, Pages 1953-1963

  Markel, Troy A ^a   Crisostomo, Paul R ^a   Lahm, Tim ^a   Novotny, Nathan M ^a   Rescorla, Frederick J ^a   Tector, Joseph ^a   Meldrum, Daniel R ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Gastrointestinal disorder; Inflammatory disorder; Ischemic disorder; Pediatric; Stem cell therapy

Indexed keywords

CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONIC STEM CELL; ENTERITIS; GASTROINTESTINAL DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFLAMMATION; MEDICAL PRACTICE; NECROTIZING ENTERITIS; NONHUMAN; PARACRINE SIGNALING; PEDIATRIC SURGERY; PRIORITY JOURNAL; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; ULCERATIVE COLITIS;

ADOLESCENT; ANIMALS; CELL LINEAGE; CHILD; CHILD, PRESCHOOL; ENTEROCOLITIS, NECROTIZING; GASTROINTESTINAL DISEASES; HUMANS; INFANT; INFLAMMATORY BOWEL DISEASES; ORGAN SPECIFICITY; PARACRINE COMMUNICATION; RATS; SHORT BOWEL SYNDROME; STEM CELL TRANSPLANTATION; STEM CELLS; TISSUE ENGINEERING; YOUNG ADULT;

EID: 55649123900     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2008.06.019     Document Type: Review

References (163)

1. Markel T.A., Crisostomo P.R., Wairiuko G.M., et al. Cytokines in necrotizing enterocolitis. Shock 25 4 (2006) 329-337
2. Nussler N.C., Muller A.R., Weidenbach H., et al. IL-10 increases tissue injury after selective intestinal ischemia/reperfusion. Ann Surg 238 1 (2003) 49-58
3. Ford H.R. Mechanism of nitric oxide-mediated intestinal barrier failure: insight into the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 41 2 (2006) 294-299
4. Neal M.D., Leaphart C., Levy R., et al. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol 176 5 (2006) 3070-3079
5. Ayala A., Song G.Y., Chung C.S., et al. Immune depression in polymicrobial sepsis: the role of necrotic (injured) tissue and endotoxin. Crit Care Med 28 8 (2000) 2949-2955
6. Cetin S., Leaphart C.L., Li J., et al. Nitric oxide inhibits enterocyte migration through activation of RhoA-GTPase in a SHP-2-dependent manner. Am J Physiol Gastrointest Liver Physiol 292 5 (2007) G1347-G1358
7. Tadros T., Traber D.L., Heggers J.P., et al. Effects of interleukin-1alpha administration on intestinal ischemia and reperfusion injury, mucosal permeability, and bacterial translocation in burn and sepsis. Ann Surg 237 1 (2003) 101-109
8. Wang S.F., Che X.M., Chen J.C., et al. Treatment of short gut syndrome with early living related small bowel transplantation. Transplant Proc 37 10 (2005) 4461-4463
9. Petty J.K., and Ziegler M.M. Operative strategies for necrotizing enterocolitis: the prevention and treatment of short-bowel syndrome. Semin Pediatr Surg 14 3 (2005) 191-198
10. Sola A., De Oca J., Gonzalez R., et al. Protective effect of ischemic preconditioning on cold preservation and reperfusion injury associated with rat intestinal transplantation. Ann Surg 234 1 (2001) 98-106
11. Khalil P.N., Weiler V., Nelson P.J., et al. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology 132 3 (2007) 944-954
12. Nagy R.D., Tsai B.M., Wang M., et al. Stem cell transplantation as a therapeutic approach to organ failure. J Surg Res 129 1 (2005) 152-160
13. Haider H., and Ashraf M. Bone marrow cell transplantation in clinical perspective. J Mol Cell Cardiol 38 2 (2005) 225-235
14. Raeburn C.D., Zimmerman M.A., Arya J., et al. Stem cells and myocardial repair. J Am Coll Surg 195 5 (2002) 686-693
15. Satija N.K., Gurudutta G.U., Sharma S., et al. Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cells Dev 16 1 (2007) 7-23
16. Xu M., Uemura R., Dai Y., et al. In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol 42 2 (2007) 441-448
17. Crisostomo P.R., Wang M., Herring C.M., et al. Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1). J Mol Cell Cardiol 42 1 (2007) 142-149
18. Uemura R., Xu M., Ahmad N., et al. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 98 11 (2006) 1414-1421
19. Crisostomo P.R., Markel T.A., Wang Y., et al. Surgically relevant aspects of stem cell paracrine effects. Surgery 143 5 (2008) 577-581
20. Wang Y., Crisostomo P.R., Wang M., et al. No suppresses the secretion of vascular endothelial growth factor and hepatocyte growth factor from human mesenchymal stem cells. Shock (2008)
21. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 5391 (1998) 1145-1147
22. Amit M., Shariki C., Margulets V., et al. Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 70 3 (2004) 837-845
23. Richards M., Fong C.Y., Chan W.K., et al. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 20 9 (2002) 933-936
24. Crisostomo P.R., Wang M., Markel T.A., et al. Stem cell mechanisms and paracrine effects: potential in cardiac surgery. Shock 28 4 (2007) 375-383
25. Gage F.H. Mammalian neural stem cells. Science 287 5457 (2000) 1433-1438
26. Weissman I.L. Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287 5457 (2000) 1442-1446
27. Ho A.D., and Punzel M. Hematopoietic stem cells: can old cells learn new tricks?. J Leukoc Biol 73 5 (2003) 547-555
28. Ferrari G., Cusella-De Angelis G., Coletta M., et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 5356 (1998) 1528-1530
29. Planat-Benard V., Silvestre J.S., Cousin B., et al. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109 5 (2004) 656-663
30. Payne T.R., Oshima H., Okada M., et al. A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts. J Am Coll Cardiol 50 17 (2007) 1677-1684
31. Wang M., Tsai B.M., Crisostomo P.R., et al. Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia. Shock 25 5 (2006) 454-459
32. Valina C., Pinkernell K., Song Y.H., et al. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. Eur Heart J 28 21 (2007) 2667-2677
33. Schachinger V., Erbs S., Elsasser A., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355 12 (2006) 1210-1221
34. Assmus B., Honold J., Schachinger V., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355 12 (2006) 1222-1232
35. Zhao Y., Huang Z., Lazzarini P., et al. A unique human blood-derived cell population displays high potential for producing insulin. Biochem Biophys Res Commun 360 1 (2007) 205-211
36. Zhang S.J., Zhang H., Hou M., et al. Is it possible to obtain "true endothelial progenitor cells" by in vitro culture of bone marrow mononuclear cells?. Stem Cells Dev 16 4 (2007) 683-690
37. Nadri S., Soleimani M., Hosseni R.H., et al. An efficient method for isolation of murine bone marrow mesenchymal stem cells. Int J Dev Biol 51 8 (2007) 723-729
38. Peister A., Mellad J.A., Larson B.L., et al. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 103 5 (2004) 1662-1668
39. Inoue S., Popp F.C., Koehl G.E., et al. Immunomodulatory effects of mesenchymal stem cells in a rat organ transplant model. Transplantation 81 11 (2006) 1589-1595
40. Lee O.K., Kuo T.K., Chen W.M., et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103 5 (2004) 1669-1675
41. Kayahara T., Sawada M., Takaishi S., et al. Candidate markers for stem and early progenitor cells, Musashi-1 and Hes1, are expressed in crypt base columnar cells of mouse small intestine. FEBS Lett 535 1-3 (2003) 131-135
42. Booth C., and Potten C.S. Gut instincts: thoughts on intestinal epithelial stem cells. J Clin Invest 105 11 (2000) 1493-1499
43. Potten C.S., Owen G., and Booth D. Intestinal stem cells protect their genome by selective segregation of template DNA strands. J Cell Sci 115 Pt 11 (2002) 2381-2388
44. Marshman E., Booth C., and Potten C.S. The intestinal epithelial stem cell. Bioessays 24 1 (2002) 91-98
45. Scoville D.H., Sato T., He X.C., et al. Current view: intestinal stem cells and signaling. Gastroenterology 134 3 (2008) 849-864
46. Barker N., van Es J.H., Kuipers J., et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449 7165 (2007) 1003-1007
47. May R., Riehl T.E., Hunt C., et al. Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells 26 3 (2008) 630-637
48. Nakamura M., Okano H., Blendy J.A., et al. Musashi, a neural RNA-binding protein required for Drosophila adult external sensory organ development. Neuron 13 1 (1994) 67-81
49. Okano H., Kawahara H., Toriya M., et al. Function of RNA-binding protein Musashi-1 in stem cells. Exp Cell Res 306 2 (2005) 349-356
50. Nishimura S., Wakabayashi N., Toyoda K., et al. Expression of Musashi-1 in human normal colon crypt cells: a possible stem cell marker of human colon epithelium. Dig Dis Sci 48 8 (2003) 1523-1529
51. Potten C.S., Booth C., Tudor G.L., et al. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 71 1 (2003) 28-41
52. Dekaney C.M., Rodriguez J.M., Graul M.C., et al. Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum. Gastroenterology 129 5 (2005) 1567-1580
53. Chiba S. Notch signaling in stem cell systems. Stem Cells 24 11 (2006) 2437-2447
54. Radtke F., and Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 307 5717 (2005) 1904-1909
55. Pinto D., and Clevers H. Wnt control of stem cells and differentiation in the intestinal epithelium. Exp Cell Res 306 2 (2005) 357-363
56. He X.C., Yin T., Grindley J.C., et al. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet 39 2 (2007) 189-198
57. Okamoto R., Yajima T., Yamazaki M., et al. Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med 8 9 (2002) 1011-1017
58. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 22 (2005) 2981-2987
59. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 10 (2005) 999-1007
60. Shimura K., Ashihara E., Shimazaki C., et al. Circulating endothelial progenitor cells decreased in patients with sclerodermatous chronic graft-versus-host disease. Biol Blood Marrow Transplant 14 4 (2008) 426-437
61. Bizzarro M.J., Bhandari V., Krause D.S., et al. Circulating stem cells in extremely preterm neonates. Acta Paediatr 96 4 (2007) 521-525
62. Dekaney C.M., Fong J.J., Rigby R.J., et al. Expansion of intestinal stem cells associated with long-term adaptation following ileocecal resection in mice. Am J Physiol Gastrointest Liver Physiol 293 5 (2007) G1013-G1022
63. Crisostomo P.R., and Meldrum D.R. Stem cell delivery to the heart: clarifying methodology and mechanism. Crit Care Med 35 11 (2007) 2654-2656
64. Vacanti J.P., Morse M.A., Saltzman W.M., et al. Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg 23 1 Pt 2 (1988) 3-9
65. Gupta A., Dixit A., Sales K.M., et al. Tissue engineering of small intestine-current status. Biomacromolecules 7 10 (2006) 2701-2709
66. Crisostomo P.R., Wang M., Wairiuko G.M., et al. High passage number of stem cells adversely affects stem cell activation and myocardial protection. Shock 26 6 (2006) 575-580
67. Crisostomo P.R., Markel T.A., Wang M., et al. In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery 142 2 (2007) 215-221
68. Markel T.A., Wang M., Crisostomo P.R., et al. Neonatal stem cells exhibit specific characteristics in function, proliferation, and cellular signaling that distinguish them from their adult counterparts. Am J Physiol Regul Integr Comp Physiol 294 5 (2008) R1491-R1497
69. Okamoto R., Matsumoto T., and Watanabe M. Regeneration of the intestinal epithelia: regulation of bone marrow-derived epithelial cell differentiation towards secretory lineage cells. Hum Cell 19 2 (2006) 71-75
70. Alison M.R., Poulsom R., Jeffery R., et al. Hepatocytes from non-hepatic adult stem cells. Nature 406 6793 (2000) 257
71. Kopen G.C., Prockop D.J., and Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A 96 19 (1999) 10711-10716
72. Poulsom R., Forbes S.J., Hodivala-Dilke K., et al. Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 195 2 (2001) 229-235
73. Hayashi Y., Tsuji S., Tsujii M., et al. The transdifferentiation of bone marrow-derived cells in colonic mucosal regeneration after dextran-sulfate-sodium-induced colitis in mice. Pharmacology 80 4 (2007) 193-199
74. Korbling M., Katz R.L., Khanna A., et al. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med 346 10 (2002) 738-746
75. Sobrino T., Hurtado O., Moro M.A., et al. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 38 10 (2007) 2759-2764
76. Ripa R.S., Haack-Sorensen M., Wang Y., et al. Bone marrow-derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation 116 11 Suppl (2007) I24-I30
77. Weiser M.M. Intestinal epithelial cell surface membrane glycoprotein synthesis. II. Glycosyltransferases and endogenous acceptors of the undifferentiated cell surface membrane. J Biol Chem 248 7 (1973) 2542-2548
78. Evans G.S., Flint N., Somers A.S., et al. The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J Cell Sci 101 Pt 1 (1992) 219-231
79. Kim S.S., Kaihara S., Benvenuto M., et al. Regenerative signals for tissue-engineered small intestine. Transplant Proc 31 1-2 (1999) 657-660
80. Kim S.S., Kaihara S., Benvenuto M.S., et al. Regenerative signals for intestinal epithelial organoid units transplanted on biodegradable polymer scaffolds for tissue engineering of small intestine. Transplantation 67 2 (1999) 227-233
81. Avansino J.R., Chen D.C., Hoagland V.D., et al. Orthotopic transplantation of intestinal mucosal organoids in rodents. Surgery 140 3 (2006) 423-434
82. Duxbury M.S., Grikscheit T.C., Gardner-Thorpe J., et al. Lymphangiogenesis in tissue-engineered small intestine. Transplantation 77 8 (2004) 1162-1166
83. Rocha F.G., Sundback C.A., Krebs N.J., et al. The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine. Biomaterials 29 19 (2008) 2884-2890
84. Grikscheit T.C., Siddique A., Ochoa E.R., et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg 240 5 (2004) 748-754
85. Park H., Cannizzaro C., Vunjak-Novakovic G., et al. Nanofabrication and microfabrication of functional materials for tissue engineering. Tissue Eng 13 8 (2007) 1867-1877
86. Lee M., Chang P.C., and Dunn J.C. Evaluation of small intestinal submucosa as scaffolds for intestinal tissue engineering. J Surg Res (2008)
87. Gilbert T.W., Stewart-Akers A.M., Sydeski J., et al. Gene expression by fibroblasts seeded on small intestinal submucosa and subjected to cyclic stretching. Tissue Eng 13 6 (2007) 1313-1323
88. Verma V., Verma P., Ray P., et al. Preparation of scaffolds from human hair proteins for tissue-engineering applications. Biomed Mater 3 2 (2008) 25007
89. Lawrence B.J., Maase E.L., Lin H.K., et al. Multilayer composite scaffolds with mechanical properties similar to small intestinal submucosa. J Biomed Mater Res A (2008)
90. Chen D.C., Avansino J.R., Agopian V.G., et al. Comparison of polyester scaffolds for bioengineered intestinal mucosa. Cells Tissues Organs 184 3-4 (2006) 154-165
91. Yixiang D., Yong T., Liao S., et al. Degradation of electrospun nanofiber scaffold by short wave length ultraviolet radiation treatment and its potential applications in tissue engineering. Tissue Eng Part A (2008)
92. Griga T., Tromm A., Schmiegel W., et al. Collagenous colitis: implications for the role of vascular endothelial growth factor in repair mechanisms. Eur J Gastroenterol Hepatol 16 4 (2004) 397-402
93. Jeschke M.G., Bolder U., Finnerty C.C., et al. The effect of hepatocyte growth factor on gut mucosal apoptosis and proliferation, and cellular mediators after severe trauma. Surgery 138 3 (2005) 482-489
94. Bulut K., Pennartz C., Felderbauer P., et al. Glucagon-like peptide-2 induces intestinal restitution through VEGF release from subepithelial myofibroblasts. Eur J Pharmacol 578 2-3 (2008) 279-285
95. Bu H.F., Zuo X.L., Wang X., et al. Milk fat globule-EGF factor 8/lactadherin plays a crucial role in maintenance and repair of murine intestinal epithelium. J Clin Invest 117 12 (2007) 3673-3683
96. Yo Y., Morishita R., Nakamura S., et al. Potential role of hepatocyte growth factor in the maintenance of renal structure: anti-apoptotic action of HGF on epithelial cells. Kidney Int 54 4 (1998) 1128-1138
97. Bardelli A., Longati P., Albero D., et al. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. Embo J 15 22 (1996) 6205-6212
98. Kosai K., Matsumoto K., Nagata S., et al. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 244 3 (1998) 683-690
99. Wang Y., Ahmad N., Wani M.A., et al. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J Mol Cell Cardiol 37 5 (2004) 1041-1052
100. Schwartz M.Z., Kato Y., Yu D., et al. Growth-factor enhancement of compromised gut function following massive small-bowel resection. Pediatr Surg Int 16 3 (2000) 174-175
101. Scalia R., Booth G., and Lefer D.J. Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: essential role of endothelium-derived nitric oxide. FASEB J 13 9 (1999) 1039-1046
102. von Dobschuetz E., Meyer S., Thorn D., et al. Targeting vascular endothelial growth factor pathway offers new possibilities to counteract microvascular disturbances during ischemia/reperfusion of the pancreas. Transplantation 82 4 (2006) 543-549
103. Wang Y., Haider H.K., Ahmad N., et al. Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair. J Mol Cell Cardiol 40 5 (2006) 736-745
104. Gerber H.P., Malik A.K., Solar G.P., et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 417 6892 (2002) 954-958
105. Han D.S., Li F., Holt L., et al. Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats. Am J Physiol Gastrointest Liver Physiol 279 5 (2000) G1011-G1022
106. Dise R.S., Frey M.R., Whitehead R.H., et al. Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration. Am J Physiol Gastrointest Liver Physiol 294 1 (2008) G276-G285
107. Zimmermann E.M., Li L., Hou Y.T., et al. Insulin-like growth factor I and insulin-like growth factor binding protein 5 in Crohn's disease. Am J Physiol Gastrointest Liver Physiol 280 5 (2001) G1022-G1029
108. Li Z., Wu J.C., Sheikh A.Y., et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 116 11 Suppl (2007) I46-I54
109. Patel K.M., Crisostomo P., Lahm T., et al. Mesenchymal stem cells attenuate hypoxic pulmonary vasoconstriction by a paracrine mechanism. J Surg Res 143 2 (2007) 281-285
110. Togel F., Hu Z., Weiss K., et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289 1 (2005) F31-F42
111. Wairiuko G.M., Crisostomo P.R., Wang M., et al. Stem cells improve right ventricular functional recovery after acute pressure overload and ischemia reperfusion injury. J Surg Res 141 2 (2007) 241-246
112. Dernbach E., Urbich C., Brandes R.P., et al. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 104 12 (2004) 3591-3597
113. Wang M., Crisostomo P.R., Herring C., et al. Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 291 4 (2006) R880-R884
114. Chen L., Tredget E.E., Wu P.Y., et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS ONE 3 4 (2008) e1886
115. Crisostomo P.R., Wang Y., Markel T.A., et al. Human mesenchymal stem cells stimulated by TNF-{alpha}, LPS, or hypoxia produce growth factors by an NF{kappa}B-but not JNK-dependent mechanism. Am J Physiol Cell Physiol 294 3 (2008) C675-C682
116. Yang S., Hu S., Choudhry M.A., et al. Anti-rat soluble IL-6 receptor antibody down-regulates cardiac IL-6 and improves cardiac function following trauma-hemorrhage. J Mol Cell Cardiol 42 3 (2007) 620-630
117. Matsutani T., Kang S.C., Miyashita M., et al. Liver cytokine production and ICAM-1 expression following bone fracture, tissue trauma, and hemorrhage in middle-aged mice. Am J Physiol Gastrointest Liver Physiol 292 1 (2007) G268-G274
118. Ayala A., Perrin M.M., Meldrum D.R., et al. Hemorrhage induces an increase in serum TNF which is not associated with elevated levels of endotoxin. Cytokine 2 3 (1990) 170-174
119. Meldrum D.R., Partrick D.A., Cleveland Jr. J.C., et al. On-pump coronary artery bypass surgery activates human myocardial NF-kappaB and increases TNF-alpha in the heart. J Surg Res 112 2 (2003) 175-179
120. Song Y., Shi Y., Ao L.H., et al. TLR4 mediates LPS-induced HO-1 expression in mouse liver: role of TNF-alpha and IL-1beta. World J Gastroenterol 9 8 (2003) 1799-1803
121. Aicher A., Rentsch M., Sasaki K., et al. Nonbone marrow-derived circulating progenitor cells contribute to postnatal neovascularization following tissue ischemia. Circ Res 100 4 (2007) 581-589
122. Elmadbouh I., Haider H., Jiang S., et al. Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 42 4 (2007) 792-803
123. Tarnawski A.S. Cellular and molecular mechanisms of gastrointestinal ulcer healing. Dig Dis Sci 50 Suppl 1 (2005) S24-S33
124. Hayashi Y., Tsuji S., Tsujii M., et al. Topical transplantation of mesenchymal stem cells accelerates gastric ulcer healing in rats. Am J Physiol Gastrointest Liver Physiol 294 3 (2008) G778-G786
125. Jaquet K., Krause K.T., Denschel J., et al. Reduction of myocardial scar size after implantation of mesenchymal stem cells in rats: what is the mechanism?. Stem Cells Dev 14 3 (2005) 299-309
126. Xu X., Xu Z., Xu Y., et al. Selective down-regulation of extracellular matrix gene expression by bone marrow-derived stem cell transplantation into infarcted myocardium. Circ J 69 10 (2005) 1275-1283
127. Crisostomo P.R., Wang M., Herring C.M., et al. Sex dimorphisms in activated mesenchymal stem cell function. Shock 26 6 (2006) 571-574
128. Ray R., Novotny N.M., Crisostomo P.R., et al. Sex steroids and stem cell function. Mol Med (2008)
129. Markel T.A., Crisostomo P.R., Wang M., et al. Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production. Am J Physiol Gastrointest Liver Physiol 293 4 (2007) G657-G662
130. Wang M., Zhang W., Crisostomo P., et al. STAT3 mediates bone marrow mesenchymal stem cell VEGF production. J Mol Cell Cardiol 42 6 (2007) 1009-1015
131. Hsieh Y.C., Frink M., Kawasaki T., et al. Downregulation of TLR4-dependent ATP production is critical for estrogen-mediated immunoprotection in Kupffer cells following trauma-hemorrhage. J Cell Physiol 211 2 (2007) 364-370
132. Kuebler J.F.J.D., Toth B., Bland K.I., et al. Estradiol administration improves splanchnic perfusion following trauma-hemorrhage and sepsis. Arch Surg 137 1 (2002) 74-79
133. Frink M., Pape H.C., van Griensven M., et al. Influence of sex and age on mods and cytokines after multiple injuries. Shock 27 2 (2007) 151-156
134. Meldrum K.K., Meldrum D.R., Meng X., et al. TNF-alpha-dependent bilateral renal injury is induced by unilateral renal ischemia-reperfusion. Am J Physiol Heart Circ Physiol 282 2 (2002) H540-H546
135. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol 274 3 Pt 2 (1998) R577-R595
136. Meldrum K.K., Metcalfe P., Leslie J.A., et al. TNF-alpha neutralization decreases nuclear factor-kappaB activation and apoptosis during renal obstruction. J Surg Res 131 2 (2006) 182-188
137. Panes J., Gomollon F., Taxonera C., et al. Crohn's disease: a review of current treatment with a focus on biologics. Drugs 67 17 (2007) 2511-2537
138. Meng X., Ao L., Meldrum D.R., et al. TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship. Am J Physiol 275 2 Pt 2 (1998) R502-R508
139. Meng X., and Harken A.H. The interaction between Hsp70 and TNF-alpha expression: a novel mechanism for protection of the myocardium against post-injury depression. Shock 17 5 (2002) 345-353
140. Pillekamp F., Reppel M., Brockmeier K., et al. Stem cells and their potential relevance to paediatric cardiology. Cardiol Young 16 2 (2006) 117-124
141. Gardner S.L. Application of stem cell transplant for brain tumors. Pediatr Transplant 8 Suppl 5 (2004) 28-32
142. Santner-Nanan B., Peek M.J., McCullagh P., et al. Therapeutic potential of stem cells in perinatal medicine. Aust N Z J Obstet Gynaecol 45 2 (2005) 102-107
143. Balasubramaniam V., Mervis C.F., Maxey A.M., et al. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 292 5 (2007) L1073-L1084
144. van Haaften T., and Thebaud B. Adult bone marrow-derived stem cells for the lung: implications for pediatric lung diseases. Pediatr Res 59 4 Pt 2 (2006) 94R-99R
145. Cuffari C. Inflammatory bowel disease in children: a pediatrician's perspective. Minerva Pediatr 58 2 (2006) 139-157
146. Latella G., Fiocchi C., and Caprilli R. Late-breaking news from the "4th International Meeting on Inflammatory Bowel Diseases" Capri, 2006. Inflamm Bowel Dis 13 8 (2007) 1031-1050
147. Ditschkowski M., Einsele H., Schwerdtfeger R., et al. Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation. Transplantation 75 10 (2003) 1745-1747
148. + cell selection in refractory Crohn's disease. Gut 57 2 (2008) 211-217
149. Srivastava A.S., Feng Z., Mishra R., et al. Embryonic stem cells ameliorate piroxicam-induced colitis in IL10-/-KO mice. Biochem Biophys Res Commun 361 4 (2007) 953-959
150. Masuda J., Mitsuyama K., Yamasaki H., et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with ulcerative colitis. Int J Mol Med 19 2 (2007) 221-228
151. Gratwohl A., Passweg J., Bocelli-Tyndall C., et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 35 9 (2005) 869-879
152. Ahmed T., Ein S., and Moore A. The role of peritoneal drains in treatment of perforated necrotizing enterocolitis: recommendations from recent experience. J Pediatr Surg 33 10 (1998) 1468-1470
153. Horwitz J.R., Lally K.P., Cheu H.W., et al. Complications after surgical intervention for necrotizing enterocolitis: a multicenter review. J Pediatr Surg 30 7 (1995) 994-998 [discussion 998-999]
154. Schimpl G., Hollwarth M.E., Fotter R., et al. Late intestinal strictures following successful treatment of necrotizing enterocolitis. Acta Paediatr Suppl 396 (1994) 80-83
155. Schulzke S.M., Deshpande G.C., and Patole S.K. Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: a systematic review of observational studies. Arch Pediatr Adolesc Med 161 6 (2007) 583-590
156. Ringden O., Uzunel M., Sundberg B., et al. Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon. Leukemia 21 11 (2007) 2271-2276
157. Hackam D.J., Reblock K.K., Redlinger R.E., et al. Diagnosis and outcome of Hirschsprung's disease: does age really matter?. Pediatr Surg Int 20 5 (2004) 319-322
158. Goulet O., and Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology 130 2 Suppl 1 (2006) S16-S28
159. Lloyd D.A., and Gabe S.M. Managing liver dysfunction in parenteral nutrition. Proc Nutr Soc 66 4 (2007) 530-538
160. Chungfat N., Dixler I., Cohran V., et al. Impact of parenteral nutrition-associated liver disease on intestinal transplant waitlist dynamics. J Am Coll Surg 205 6 (2007) 755-761
161. Ladd A.P., Grosfeld J.L., Pescovitz O.H., et al. The effect of growth hormone supplementation on late nutritional independence in pediatric patients with short bowel syndrome. J Pediatr Surg 40 2 (2005) 442-445
162. Pereira P.M., and Bines J.E. New growth factor therapies aimed at improving intestinal adaptation in short bowel syndrome. J Gastroenterol Hepatol 21 6 (2006) 932-940
163. Modi B.P., Javid P.J., Jaksic T., et al. First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications. J Am Coll Surg 204 3 (2007) 365-371